120 related articles for article (PubMed ID: 8104684)
41. Effect of the antihistamine, methapyrilene, as an initiator of hepatocarcinogenesis in female rats.
Glauert HP; Pitot HC
Cancer Lett; 1989 Aug; 46(3):189-94. PubMed ID: 2569926
[TBL] [Abstract][Full Text] [Related]
42. Hepatic protein pattern alterations following perfluorodecanoic acid exposure in rats.
Witzmann FA; Parker DN
Toxicol Lett; 1991 Jun; 57(1):29-36. PubMed ID: 2048159
[TBL] [Abstract][Full Text] [Related]
43. The effects of perfluorodecanoic acid on hepatic stearoyl-coenzyme A desaturase and mixed function oxidase activities in rats.
Van Rafelghem MJ; Andersen ME
Fundam Appl Toxicol; 1988 Oct; 11(3):503-10. PubMed ID: 2906022
[TBL] [Abstract][Full Text] [Related]
44. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.
Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
J Environ Pathol Toxicol Oncol; 1992; 11(3):145-9. PubMed ID: 1625184
[TBL] [Abstract][Full Text] [Related]
45. Suppression of altered hepatic foci development by a high fish oil diet compared with a high corn oil diet in rats.
Lii CK; Ou CC; Liu KL; Liu JY; Lin WL; Chen HW
Nutr Cancer; 2000; 38(1):50-9. PubMed ID: 11341044
[TBL] [Abstract][Full Text] [Related]
46. Perfluorodecanoic acid decreases the enzyme activity and the amount of glutathione S-transferases proteins and mRNAs in vivo.
Schramm H; Friedberg T; Robertson LW; Oesch F; Kissel W
Chem Biol Interact; 1989; 70(1-2):127-43. PubMed ID: 2736674
[TBL] [Abstract][Full Text] [Related]
47. No inhibition of gamma-glutamyl transpeptidase-positive foci by vitamin E with or without phenobarbital.
Lii CK; Ko JJ; Chen HW
Nutr Cancer; 1997; 27(2):200-5. PubMed ID: 9121950
[TBL] [Abstract][Full Text] [Related]
48. The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells.
Boujrad N; Vidic B; Gazouli M; Culty M; Papadopoulos V
Endocrinology; 2000 Sep; 141(9):3137-48. PubMed ID: 10965884
[TBL] [Abstract][Full Text] [Related]
49. Effects of perfluorodecanoic acid on hepatic indices of thyroid status in the rat.
Kelling CK; Van Rafelghem MJ; Menahan LA; Peterson RE
Biochem Pharmacol; 1987 Apr; 36(8):1337-44. PubMed ID: 3593420
[TBL] [Abstract][Full Text] [Related]
50. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
[TBL] [Abstract][Full Text] [Related]
51. The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats.
Bunaciu RP; Tharappel JC; Lehmler HJ; Kania-Korwel I; Robertson LW; Srinivasan C; Spear BT; Glauert HP
Toxicology; 2007 Oct; 239(3):147-55. PubMed ID: 17703865
[TBL] [Abstract][Full Text] [Related]
52. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital.
Goldsworthy TL; Pitot HC
Carcinogenesis; 1985 Sep; 6(9):1261-9. PubMed ID: 2863007
[TBL] [Abstract][Full Text] [Related]
53. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
[TBL] [Abstract][Full Text] [Related]
54. Effect of dietary selenium on the induction of altered hepatic foci and hepatic tumors by the peroxisome proliferator ciprofibrate.
Glauert HP; Beaty MM; Clark TD; Greenwell WS; Chow CK
Nutr Cancer; 1990; 14(3-4):261-71. PubMed ID: 2084622
[TBL] [Abstract][Full Text] [Related]
55. Promoting activity of the herbicide dicamba (2-methoxy-3, 6-dichlorobenzoic acid) in two stage hepatocarcinogenesis.
Espandiari P; Glauert HP; Lee EY; Robertson LW
Int J Oncol; 1999 Jan; 14(1):79-84. PubMed ID: 9863012
[TBL] [Abstract][Full Text] [Related]
56. Effects of perfluorodecanoic acid on de novo fatty acid and cholesterol synthesis in the rat.
Davis JW; Vanden Heuvel JP; Peterson RE
Lipids; 1991 Oct; 26(10):857-9. PubMed ID: 1795607
[TBL] [Abstract][Full Text] [Related]
57. Corn oil enhances gamma-glutamyl transpeptidase-positive foci development in the presence of phenobarbital during hepatocarcinogenesis in rats.
Chen HW; Ko JJ; Lii CK; Ou CC; Sheen LY
Nutr Cancer; 1997; 28(3):252-7. PubMed ID: 9343833
[TBL] [Abstract][Full Text] [Related]
58. Interrelationships between energy and fat metabolism and hypophagia in rats treated with perfluorodecanoic acid.
Van Rafelghem MJ; Noren CW; Menahan LA; Peterson RE
Toxicol Lett; 1988 Jan; 40(1):57-69. PubMed ID: 3124303
[TBL] [Abstract][Full Text] [Related]
59. Toxicokinetics of perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) in male and female Hsd:Sprague dawley SD rats following intravenous or gavage administration.
Dzierlenga AL; Robinson VG; Waidyanatha S; DeVito MJ; Eifrid MA; Gibbs ST; Granville CA; Blystone CR
Xenobiotica; 2020 Jun; 50(6):722-732. PubMed ID: 31680603
[TBL] [Abstract][Full Text] [Related]
60. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis.
Xu YH; Maronpot R; Pitot HC
Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
